|
N-[2-(diethylaMino)ethyl]-2,4-diMethyl-1H-pyrrole-3-carboxaMide
|
N-(2-(二乙基氨基)乙基)-2,4-二甲基-1H-吡咯-3-甲酰胺
|
590424-05-8
|
|
N-(2-Pyrazinecarbonyl)-D-phenylalanine-D-leucine boronic anhydride
|
硼替佐米杂质L
|
1132709-16-0
|
|
Sunitinib iMpurity C
|
Sunitinib iMpurity C
|
|
|
tert-butyl (3-bromo-5-(trifluoromethyl)phenyl)carbamate
|
|
641571-03-0
|
|
N-(2-(DiethylaMino)ethyl)-5-forMyl-2,4-diMethyl-1H-pyrrole-3-carboxaMide
|
N-(2-(二乙基氨基)乙基)-5-甲酰基-2,4-二甲基-1H-吡咯-3-甲酰胺
|
356068-86-5
|
|
N-(Trans-4-(4-(cyclopropylMethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-Methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)aMino)-3-MethoxybenzaMide
|
N-[反式-4-[4-(环丙基甲基)-1-哌嗪基]环己基]-4-[[(7R)-7-乙基-5,6,7,8-四氢-5-甲基-8-异丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺
|
755038-65-4
|
|
N-(2-Pyrazinecarbonyl)-L-phenylalanine-D-leucine boronic anhydride
|
硼替佐米杂质E
|
1132709-14-8
|
|
Riociguat iMpurity-2-1
|
|
|
|
Sunitinib iMpurity E
|
舒尼替尼杂质E
|
|
|
Nilotinib iMpurity B
|
|
|
|
Olaparib iMpurity D
|
奥拉帕利杂质D
|
|
|
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
|
N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺
|
477600-74-1
|
|
tert-butyl ((S)-4-Methyl-1-((R)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)carbaMate
|
((1S)-3-甲基-1-(((2R)-2-甲基环氧乙基)羰基)丁基)氨基甲酸叔丁酯
|
247068-82-2
|
|
Olaparib iMpurity A
|
奥拉帕利杂质A
|
|
|
Trans-4-?[4-?(cyclopropylMethyl)?-?1-?piperazinyl]?-?cyclohexanaMine hydrochloride (1:?)
|
反式-4- [4-(环丙基甲基)-1-哌嗪基] - 环己烷盐酸盐(1 :)
|
876371-19-6
|
|
N-((S)-1-(((S)-1-hydroperoxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide
|
硼替佐米杂质K
|
886979-81-3
|
|
Sunitinib iMpurity A
|
Sunitinib iMpurity A
|
|
|
Sunitinib iMpurity F
|
舒尼替尼杂质F
|
|
|
N-(2-chloro-6-Methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-MethylpyriMidin-4-yl)aMino)thiazole-5-carboxaMide
|
达沙替尼
|
302962-49-8
|
|
tert-butyl 4-[[[2-(diethylaMino)ethyl]aMino]carbonyl]-3,5-diMethyl-1H-pyrrole-2-carboxylate
|
舒尼替尼中间体3
|
590424-04-7
|
|
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7-tosyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
|
N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7-((4-甲基苯基)磺酰基)7H-吡咯并[2,3-D]嘧啶-4-胺
|
923036-30-0
|
|
Nilotinib iMpurity C
|
|
|
|
Riociguat iMpurity-1
|
|
|
|
N-PYRAZINYLCARBONYLPHENYLALANINE METHYL ESTER
|
硼替佐米杂质G
|
73058-37-4
|
|
1-BOC-4-(6-AMINOPYRIDIN-3-YL)PIPERAZINE
|
4-(6-氨基-3-吡啶基)-1-BOC-哌嗪
|
571188-59-5
|
|
N-(2-Pyrazinecarbonyl)-D-phenylalanine-L-leucine boronic anhydride
|
硼替佐米杂质-异构体
|
1132709-15-9
|
|
Olaparib iMpurity B
|
奥拉帕利杂质B
|
|
|
N-((S)-1-(((R)-1-hydroperoxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide
|
硼替佐米杂质K
|
886979-78-8
|
|
Sunitinib iMpurity B
|
Sunitinib iMpurity B
|
|
|
Volasertib iMpurity A
|
|
|
|
4-chloroquinolin-8-amine
|
4-氯-8-氨基喹啉
|
81764-16-1
|
|
Nilotinib iMpurity D
|
|
|
|
Riociguat iMpurity2
|
|
|
|
Sunitinib iMpurity D
|
Sunitinib iMpurity D
|
|
|
Nilotinib iMpurity A
|
|
|
|
Olaparib iMpurity C
|
奥拉帕利杂质C
|
|
|
N-(2-diethylaMinoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)Meth yl]-2,4-diMethyl-1H-pyrrole-3-carboxaMide
|
舒尼替尼
|
557795-19-4
|